Ascendis Pharma A/S (ASND) News Today $194.27 +0.37 (+0.19%) Closing price 04:00 PM EasternExtended Trading$194.23 -0.04 (-0.02%) As of 04:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ASND Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Ascendis Pharma to Participate in the 2025 Wells Fargo Healthcare ConferenceAugust 28 at 6:36 PM | finance.yahoo.comAscendis Pharma to Participate in the 2025 Wells Fargo Healthcare ConferenceAugust 28 at 4:01 PM | globenewswire.comAscendis Pharma A/S $ASND Position Boosted by Campbell & CO Investment Adviser LLCAugust 27 at 7:13 AM | marketbeat.comAlgert Global LLC Takes Position in Ascendis Pharma A/S $ASNDAugust 27 at 4:02 AM | marketbeat.comPrice T Rowe Associates Inc. MD Lowers Stock Position in Ascendis Pharma A/S $ASNDAugust 26 at 4:58 AM | marketbeat.comResolute Capital Asset Partners LLC Acquires 53,000 Shares of Ascendis Pharma A/S $ASNDAugust 25, 2025 | marketbeat.comAscendis Pharma A/S $ASND is Q Global Advisors LLC's 2nd Largest PositionAugust 25, 2025 | marketbeat.comHighTower Advisors LLC Acquires 14,518 Shares of Ascendis Pharma A/S $ASNDAugust 25, 2025 | marketbeat.comWellington Management Group LLP Sells 116,412 Shares of Ascendis Pharma A/S $ASNDAugust 24, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Given Consensus Rating of "Buy" by AnalystsAugust 24, 2025 | marketbeat.comAtika Capital Management LLC Makes New $5.49 Million Investment in Ascendis Pharma A/S $ASNDAugust 23, 2025 | marketbeat.comAscendis Pharma A/S $ASND Shares Sold by Candriam S.C.A.August 22, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Buys 328,278 Shares of Ascendis Pharma A/S $ASNDAugust 22, 2025 | marketbeat.comAscendis: After Long Bull Run, New Commercial Challenges Suggest Rating DowngradeAugust 21, 2025 | seekingalpha.comAscendis Pharma A/S (NASDAQ:ASND) Price Target Raised to $260.00August 21, 2025 | marketbeat.comAscendis Pharma A/S $ASND Stake Raised by American Century Companies Inc.August 21, 2025 | marketbeat.comAberdeen Group plc Sells 15,449 Shares of Ascendis Pharma A/S $ASNDAugust 20, 2025 | marketbeat.comAscendis Pharma price target raised to $260 from $254 at JPMorganAugust 20, 2025 | msn.comSector Gamma AS Purchases New Shares in Ascendis Pharma A/S (NASDAQ:ASND)August 17, 2025 | marketbeat.comNew Forecasts: Here's What Analysts Think The Future Holds For Ascendis Pharma A/S (NASDAQ:ASND)August 16, 2025 | finance.yahoo.comAscendis Pharma A/S (NASDAQ:ASND) Position Boosted by Invesco Ltd.August 15, 2025 | marketbeat.comPersistent Asset Partners Ltd Has $297,000 Stock Position in Ascendis Pharma A/S (NASDAQ:ASND)August 13, 2025 | marketbeat.comAscendis Pharma A/S Q2 Earnings Call Highlights GrowthAugust 13, 2025 | msn.comAscendis Pharma A/S (NASDAQ:ASND) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | msn.comAscendis Pharma A/S (NASDAQ:ASND) Reaches New 1-Year High After Analyst UpgradeAugust 12, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Releases Quarterly Earnings Results, Beats Estimates By $0.49 EPSAugust 11, 2025 | marketbeat.comChicago Partners Investment Group LLC Sells 1,654 Shares of Ascendis Pharma A/S (NASDAQ:ASND)August 11, 2025 | marketbeat.comNew Age Alpha Advisors LLC Cuts Stock Holdings in Ascendis Pharma A/S (NASDAQ:ASND)August 11, 2025 | marketbeat.comCitigroup Forecasts Strong Price Appreciation for Ascendis Pharma A/S (NASDAQ:ASND) StockAugust 10, 2025 | marketbeat.comRoyal Bank Of Canada Boosts Ascendis Pharma A/S (NASDAQ:ASND) Price Target to $230.00August 10, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Raised to "Buy" at Wall Street ZenAugust 10, 2025 | marketbeat.comUBS Group Issues Positive Forecast for Ascendis Pharma A/S (NASDAQ:ASND) Stock PriceAugust 9, 2025 | marketbeat.comWedbush Forecasts Strong Price Appreciation for Ascendis Pharma A/S (NASDAQ:ASND) StockAugust 9, 2025 | marketbeat.comCantor Fitzgerald Issues Positive Forecast for Ascendis Pharma A/S (NASDAQ:ASND) Stock PriceAugust 9, 2025 | marketbeat.comStifel Nicolaus Boosts Ascendis Pharma A/S (NASDAQ:ASND) Price Target to $254.00August 9, 2025 | marketbeat.com2,111 Shares in Ascendis Pharma A/S (NASDAQ:ASND) Purchased by Altfest L J & Co. Inc.August 9, 2025 | marketbeat.comAscendis Pharma A/S (ASND) Q2 2025 Earnings Call TranscriptAugust 9, 2025 | seekingalpha.comAscendis Pharma shares rise on narrower-than-feared Q2 loss, revenue beatAugust 8, 2025 | in.investing.comStocks To Watch: Ascendis Pharma ADR Sees RS Rating Rise To 92August 8, 2025 | msn.comAscendis Pharma Reports Second Quarter 2025 Financial ResultsAugust 7, 2025 | globenewswire.comXTX Topco Ltd Buys New Shares in Ascendis Pharma A/S (NASDAQ:ASND)August 6, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Sets New 52-Week High - Time to Buy?August 5, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) is Westfield Capital Management Co. LP's Largest PositionAugust 5, 2025 | marketbeat.comEvolutionary Tree Capital Management LLC Has $3.22 Million Stock Holdings in Ascendis Pharma A/S (NASDAQ:ASND)August 5, 2025 | marketbeat.comAscendis Pharma’s Clinical Trial Update: Implications for InvestorsAugust 1, 2025 | tipranks.comAscendis Pharma to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025July 31, 2025 | globenewswire.comAscendis Pharma A/S (NASDAQ:ASND) Price Target Raised to $254.00July 30, 2025 | marketbeat.comFDA Approves SKYTROFA® (Lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Adults with Growth Hormone DeficiencyJuly 28, 2025 | globenewswire.comTD Asset Management Inc Increases Stock Holdings in Ascendis Pharma A/S (NASDAQ:ASND)July 28, 2025 | marketbeat.comAscendis Pharma A/S (NASDAQ:ASND) Receives Consensus Rating of "Buy" from AnalystsJuly 28, 2025 | marketbeat.com Get Ascendis Pharma A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for ASND and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ASND Media Mentions By Week ASND Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ASND News Sentiment▼1.411.03▲Average Medical News Sentiment ASND News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ASND Articles This Week▼128▲ASND Articles Average Week Get the Latest News and Ratings for ASND and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Ascendis Pharma A/S and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ARGX News Today ONC News Today INSM News Today BNTX News Today TEVA News Today SMMT News Today GMAB News Today VTRS News Today RDY News Today QGEN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ASND) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ascendis Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Ascendis Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access